States reach deal over marketing, safety of generic opioids
A former opioid manufacturer is agreeing in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices. State attorneys general announced the deal Friday regarding Allergan's practices. Allergan is…